Aberrant N-glycosylation may be a therapeutic target in carriers of a common and highly pleiotropic variant in the manganese transporter ZIP8
Summary: The treatment of defective glycosylation in clinical practice has been limited to patients with rare and severe phenotypes associated with congenital disorders of glycosylation (CDGs). Carried by approximately 5% of the human population, the discovery of the highly pleiotropic, missense var...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2026-01-01
|
| Serie: | HGG Advances |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2666247725001204 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|